迷迭香酸
哮喘
肠道菌群
药理学
医学
特应性皮炎
TLR4型
人口
免疫学
生物
炎症
生物化学
抗氧化剂
环境卫生
作者
Huihui Guo,Yanxing Han,Xiaojuan Rong,Zhen Shen,Hao-Ran Shen,Lingfei Kong,Yanping Guo,Jizhou Li,Bo Zhang,Tianle Gao,Lu‐Lu Wang,Cai Tie,Jian‐Dong Jiang
出处
期刊:Phytomedicine
[Elsevier]
日期:2024-02-20
卷期号:126: 155470-155470
被引量:1
标识
DOI:10.1016/j.phymed.2024.155470
摘要
Asthma affects 3% of the global population, leading to over 0.25 million deaths. Due to its complexity, asthma is difficult to cure or prevent, and current therapies have limitations. This has led to a growing demand for alternative asthma treatments. We found rosmarinic acid (RosA) as a potential new drug candidate from natural medicine. However, RosA has poor bioavailability and remains mainly in the gastrointestinal tract after oral administration, suggesting the involvement of gut microbiota in its bioactivity.
科研通智能强力驱动
Strongly Powered by AbleSci AI